| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9974831 | The Journal of Heart and Lung Transplantation | 2005 | 6 Pages |
Abstract
Rituximab is beneficial for treatment of vascular rejection. Further study is indicated to verify the safety, efficacy and mechanism of action of rituximab therapy for vascular rejection.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
H. Edward MD, Denise RN, BSN, Beth RN, BSN, Kenneth MD,